Member Info for Laura2022

From yesterday

VAL

There apparently is a Musk/tesla link to CPX and DGI (AIM company ),

Maxwell and CAP-XX have an agreement in principle and are in final negotiations to ensure that this issue and all litigation matters with Maxwell/Tesla are resolved as soon as possible. These negotiations are anticipated to be completed in the coming weeks.

It would be normal to tweet from the conference , they do it at every conference?

I think you have a point

Not quite sure why my email summary was deleted ?

People can email the company themselves and I assume grt the same reply

Sorry to hear that makemine

I have bought and can sell all 6mln shares as surely they can at least sell some inventory or secure other avenues via mgmt based solution

Personally I'm glad that traders are deterred who buy and sell for 5% ,however would be good to have a more realistic spread as you say

Of you look at results across AIM this last month PYC are one of the few that are growing revenues and reducing losses !

Hopefully hear more from the conference and see some director buys

The cash position is very restricted in today's RNS

In situations like they usually say "we have unconditional acceptances of X % to bcl the proposal "

But yesterday's RNS says nothing....unless that comes with the forthcoming circular?

Household name

Great news

Mgmt should be ashamed but they won't be

Constantly throwing away money since listing

Shareholders treated awfully

The pricing is on the Web link...

If one pays x but gets Y back in contracts after meeting clients then it's clearly worth it

Merck Sept 2023 contract said more before end of financial year while Bicycle have regularly been expanding their spending with PYC

This is what oeter said in interins

A significant number of new client contracts are now originating from both scientific conferences (such as EORTC-NCI-AACR & AACR Annual Meeting) as well as more business focused meetings (such as BioEurope) and as such the Company intends to significantly increase its presence at such meetings over the course of this calendar year.

Thanks Debull

Some large names like AstraZeneca there too..also Bicycle are doing

A main presentation on one of the days about their programme of assets

Several complementary options are being pursued simultaneously to build out this new capability and a further update will be provided to the market towards the end of the current financial year. We anticipate that, if successful, this new service line could make a material contribution

I am going to ask about this for the pre submitted questions

Thanks frankie

Full year 2023 total revenue and other income of $17.5m compared to $6.2m in 2022

 

Full year 2023 Accrufer® revenue of $11.6m, approximately three times more than the prior year

 

21% increase in H2 Accrufer® average net selling price to $145/prescription

 

Thanks Trench

I purchased some this morning

The cash of $17mln is re qssuring and the fall from 6p seems a bid over the top